Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

“Skin rashes” and immunotherapy in melanoma: distinct dermatologic adverse events and implications for therapeutic management
Pietro Sollena, Simone Cappilli, Francesco Federico, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 18, Iss. 3
Open Access | Times Cited: 10

Showing 10 citing articles:

Molecular biology of the novel anticancer medications: a focus on kinases inhibitors, biologics and CAR T-cell therapy
Eman M. Abdo, Imad Ajib, Jason El Mounzer, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Closed Access | Times Cited: 1
Skin Microbiome and Treatment-Related Skin Toxicities in Patients With Cancer: A Mini-Review
Brianna N. Richardson, Jolinta Lin, Zachary S. Buchwald, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 23
Dermatologic toxicities related to cancer immunotherapy
Yosra Vaez-Gharamaleki, Mohammad Amin Akbarzadeh, Farhad Jadidi‐Niaragh, et al.
Toxicology Reports (2025), pp. 102021-102021
Open Access
Advancing immunotherapy using biomaterials to control tissue, cellular, and molecular level immune signaling in skin
Shrey Shah, Robert S. Oakes, Christopher M. Jewell
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115315-115315
Closed Access | Times Cited: 2
Mucocutaneous adverse events to immune checkpoint inhibitors
Fiorinda F. Muhaj, Padmavathi V. Karri, Wylie Moody, et al.
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 5
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis
José A. Gómez‐Puerta, Karolina Gente, Tamiko R. Katsumoto, et al.
Rheumatic Disease Clinics of North America (2024) Vol. 50, Iss. 2, pp. 161-179
Closed Access | Times Cited: 1
ΔM4: Membrane-Active Peptide with Antitumoral Potential against Human Skin Cancer Cells
Estefanía Fandiño-Devia, Gloria A. Santa-González, Maria C. Klaiss-Luna, et al.
Membranes (2023) Vol. 13, Iss. 7, pp. 671-671
Open Access | Times Cited: 2
LC‐OCT for early diagnosis and characterization of dermatologic adverse events to oncologic drugs and correlation to histopathology
Pietro Sollena, Marisa Salvi, Marica Marraffa, et al.
International Journal of Dermatology (2024)
Open Access
Editorial of special focus on melanoma immunotherapy
Ernesto Rossi
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 3
Open Access
Skin affecting adverse events of immunotherapies for the treatment of malignancies
Daniella Kuzmanovszki, Norbert Kiss, Béla Tóth, et al.
Bőrgyógyászati és Venerológiai Szemle (2022) Vol. 98, Iss. 5, pp. 264-274
Open Access
Page 1

Scroll to top